Net delta exposure for Harmony Biosciences Holdings Inc (HRMY) options was -$12.41M per 1% move at the Nov 13, 2026 close. It has been positive on 0 of the last 20 trading days. Four weeks earlier, on Oct 16, 2026, it was -$1.91M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for HRMY, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for HRMY, 2026-11-20(m), calls & puts
| Net DEX ($ per 1% move) | $204.81K |
|---|---|
| Call DEX ($ per 1% move) | $555.26K |
| Put DEX ($ per 1% move) | -$350.45K |
| Call Wall | |
| Put Wall |
Net Delta Exposure by Expiration
Showing results for HRMY, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|---|---|---|---|---|
| Nov 20, 2026 5 DTE monthly | $204.81K | $555.26K | -$350.45K |
HRMY Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is HRMY delta exposure positive or negative?
Harmony Biosciences net delta exposure was negative on Nov 13, 2026, at -$12.41M. It has been positive on 0 of the last 20 trading days.
How has HRMY delta exposure changed recently?
Harmony Biosciences net delta exposure went from -$1.91M on Oct 16, 2026 to -$12.41M on Nov 13, 2026. See the HRMY delta exposure history for a longer view.
What is Harmony Biosciences Holdings Inc?
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs.